subject area of
- Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report. Academic Article
- The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies Academic Article
- When Is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant? Academic Article
- When is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant? Academic Article